In his early 80s, Dr. Mitchell Sheinkop was no stranger to the realities of joint degeneration. As a practicing orthopedic surgeon and the Medical Director of QC Kinetix, he understood the potential complications of major joint surgery at his age. 

‍

Years of osteoarthritis in both knees, his left hip, and low back had left him in pain and with diminished ability to walk. Standard treatment options offered by local providers in Chicago were no longer producing meaningful results. 

‍

But Dr. Sheinkop wasn’t ready to trade in his active lifestyle for a cane—or the surgical table.

Having collaborated professionally with Dr. Chris Rogers on several research projects over the years, Dr. Sheinkop sought him out—not as a peer this time, but as a patient. 

‍

After reviewing his condition and discussing options, Dr. Rogers recommended autologous (your own cells) stem cell therapy through Personalized Stem Cells (PSC)—a treatment using the patient’s own fat-derived stem cells, expanded under strict FDA-regulated conditions. 

‍

Dr. Sheinkop’s treatment process included: 

1. Initial Consultation & Eligibility Screening – Confirmed diagnoses and discussed treatment under the Federal Right-to-Try pathway. 

2. Mini-Lipoaspiration Procedure – Adipose tissue was harvested from Dr. Sheinkop’s flanks under local anesthesia, with minimal discomfort. 

3. Laboratory Expansion – The sample was sent to PSC’s FDA-inspected lab, where stem cells were isolated and expanded over approximately 60 days. 

4. Cellular Treatment – Upon his return to San Diego, Dr. Rogers delivered targeted image-guided injections to both knees, the left hip, and the low back. The treatment delivered approximately 18 million autologous stem cells in a sterile, pharmaceutical-grade product. 

Now two years post-treatment, Dr. Sheinkop has not only avoided surgery—he’s thriving. His active lifestyle continues uninterrupted, and his mobility has been restored across multiple major joints. 

‍

“This past weekend was devoted to fly fishing in Southwest Wisconsin, walking on very uneven terrain both in and out of the creek. Yesterday, I devoted 45 minutes to intensive training on my Concept 2 rowing ergometer. This afternoon, I have set time aside for an hour of indoor cycling at a fairly competitive RPM and resistance. Without the interventions by Dr. Rogers, I probably would be an old guy with a cane.” 

This case study is for informational purposes only and is intended to share one individual’s personal experience. No claims are being made regarding the safety, efficacy, or outcomes of stem cell therapy for any condition. Individual results may vary based on a variety of factors, and there is no guarantee of specific outcomes.The stem cell therapy referenced in this case study is considered investigational and has not been approved by the FDA for general use. Personalized Stem Cells (PSC) has conducted a Phase 1/2a clinical trial under FDA authorization to evaluate the safety and potential effectiveness of autologous adipose-derived stem cell therapy for knee osteoarthritis. Additional clinical research is ongoing.Patients seeking stem cell therapy through PSC may do so through FDA-regulated Expanded Access (Compassionate Use) or the Federal Right-to-Try Act, if eligibility criteria are met. Always consult with your physician before pursuing any medical treatment.

This case study is for informational purposes only and is intended to share one individual’s personal experience. No claims are being made regarding the safety, efficacy, or outcomes of stem cell therapy for any condition. Individual results may vary based on a variety of factors, and there is no guarantee of specific outcomes.The stem cell therapy referenced in this case study is considered investigational and has not been approved by the FDA for general use. Personalized Stem Cells (PSC) has conducted a Phase 1/2a clinical trial under FDA authorization to evaluate the safety and potential effectiveness of autologous adipose-derived stem cell therapy for knee osteoarthritis. Additional clinical research is ongoing.Patients seeking stem cell therapy through PSC may do so through FDA-regulated Expanded Access (Compassionate Use) or the Federal Right-to-Try Act, if eligibility criteria are met. Always consult with your physician before pursuing any medical treatment.